Paper39338299
A Comprehensive Review of Silver and Gold Nanoparticles as Effective Antibacterial Agents.
Aguilar-Garay R and 7 others. Pharmaceuticals (Basel), 2024. Cited by 48 papers, by iCite.
Cite this record
ConductScience Library. A Comprehensive Review of Silver and Gold Nanoparticles as Effective Antibacterial Agents. Papers, record 39338299. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39338299
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A Comprehensive Review of Silver and Gold Nanoparticles as Effective Antibacterial Agents.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References99
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36838334 | Silver Nanoparticles: Bactericidal and Mechanistic Approach against Drug Resistant Pathogens. | Microorganisms | 2023 | https://conductscience.org/library/papers/36838334 | PubMed |
| 2 | 27977746 | Two-Phase Bactericidal Mechanism of Silver Nanoparticles against Burkholderia pseudomallei. | PLoS One | 2016 | https://conductscience.org/library/papers/27977746 | PubMed |
| 3 | 33530434 | Gold Nanoparticles: Can They Be the Next Magic Bullet for Multidrug-Resistant Bacteria? | Nanomaterials (Basel) | 2021 | https://conductscience.org/library/papers/33530434 | PubMed |
| 4 | 25450183 | Antibacterial effect of silver nanoparticles and the modeling of bacterial growth kinetics using a modified Gompertz model. | Biochim Biophys Acta | 2015 | https://conductscience.org/library/papers/25450183 | PubMed |
| 5 | 29452593 | A review on biosynthesis of silver nanoparticles and their biocidal properties. | J Nanobiotechnology | 2018 | https://conductscience.org/library/papers/29452593 | PubMed |
| 6 | 24801405 | Silver nanoparticles synthesized by pulsed laser ablation: as a potent antibacterial agent for human enteropathogenic gram-positive and gram-negative bacterial strains. | Appl Biochem Biotechnol | 2014 | https://conductscience.org/library/papers/24801405 | PubMed |
| 7 | 36368469 | Contribution to optimization and standardization of antibacterial assays with silver nanoparticles: the culture medium and their aggregation. | J Microbiol Methods | 2022 | https://conductscience.org/library/papers/36368469 | PubMed |
| 8 | 27754645 | Composite Porous Silicon-Silver Nanoparticles as Theranostic Antibacterial Agents. | ACS Appl Mater Interfaces | 2016 | https://conductscience.org/library/papers/27754645 | PubMed |
| 9 | 28419240 | From Nano to Micro: using nanotechnology to combat microorganisms and their multidrug resistance. | FEMS Microbiol Rev | 2017 | https://conductscience.org/library/papers/28419240 | PubMed |
| 10 | 36364482 | Biogenic Silver Nanoparticles from Two Varieties of Agaricus bisporus and Their Antibacterial Activity. | Molecules | 2022 | https://conductscience.org/library/papers/36364482 | PubMed |
| 11 | 35551489 | Green synthesis and antibacterial applications of gold and silver nanoparticles from Ligustrum vulgare berries. | Sci Rep | 2022 | https://conductscience.org/library/papers/35551489 | PubMed |
| 12 | 37842655 | Applications and safety of gold nanoparticles as therapeutic devices in clinical trials. | J Pharm Anal | 2023 | https://conductscience.org/library/papers/37842655 | PubMed |
| 13 | 29134123 | Green synthesis of capped gold nanoparticles and their effect on Gram-positive and Gram-negative bacteria. | Future Sci OA | 2017 | https://conductscience.org/library/papers/29134123 | PubMed |
| 14 | 33402822 | Lethal Mechanisms of Nostoc-Synthesized Silver Nanoparticles Against Different Pathogenic Bacteria. | Int J Nanomedicine | 2020 | https://conductscience.org/library/papers/33402822 | PubMed |
| 15 | 34904119 | The Effect of Gold Nano Particles with Different Sizes on Streptococcus Species. | J Dent (Shiraz) | 2021 | https://conductscience.org/library/papers/34904119 | PubMed |
| 16 | 26072980 | Antimicrobial Activity of Gold Nanoparticles and Ionic Gold. | J Environ Sci Health C Environ Carcinog Ecotoxicol Rev | 2015 | https://conductscience.org/library/papers/26072980 | PubMed |
| 17 | 34281254 | Silver Nanoparticles and Their Antibacterial Applications. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34281254 | PubMed |
| 18 | 32050443 | Metal-Based Nanoparticles as Antimicrobial Agents: An Overview. | Nanomaterials (Basel) | 2020 | https://conductscience.org/library/papers/32050443 | PubMed |
| 19 | 27101926 | Preparation of gold nanoparticles by novel bacterial exopolysaccharide for antibiotic delivery. | Life Sci | 2016 | https://conductscience.org/library/papers/27101926 | PubMed |
| 20 | 37402428 | Nanoparticles-based therapeutics for the management of bacterial infections: A special emphasis on FDA approved products and clinical trials. | Eur J Pharm Sci | 2023 | https://conductscience.org/library/papers/37402428 | PubMed |
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42825009 | Fluorescent Biofunctionalized Silver and Gold Nanoparticles: Bright Tools for Bioimaging Applications. | ACS Omega | 2026 | https://conductscience.org/library/papers/42825009 | PubMed |
| 42738763 | Fungal-Based Biogenic Silver Nanoparticles: Synthesis, Mathematical Modeling and Application. | Molecules | 2026 | https://conductscience.org/library/papers/42738763 | PubMed |
| 42655071 | Microbial Synthesis of Precious Metal Nanoparticles and Their Applications: A Review. | Microorganisms | 2026 | https://conductscience.org/library/papers/42655071 | PubMed |
| 42592093 | Sustainable nanomedicine:green synthesis of functional nanomaterials and its applications. | Front Chem | 2026 | https://conductscience.org/library/papers/42592093 | PubMed |
| 42548778 | Nanosystems for delivery of indolicidin peptide. | Front Med Technol | 2026 | https://conductscience.org/library/papers/42548778 | PubMed |
| 42423746 | Silver-based N-heterocyclic carbene (NHC) complexes as emerging strategies against antimicrobial resistance. | Arch Microbiol | 2026 | https://conductscience.org/library/papers/42423746 | PubMed |
| 42391307 | Biogenic Silver-Selenium nanocomposite with anticancer activity and potent efficacy against vancomycin-resistant Staphylococcus aureus. | PLoS One | 2026 | https://conductscience.org/library/papers/42391307 | PubMed |
| 42353108 | Tuning Anticancer Activity and Antimicrobial Response of ZnO Nanoparticles Through Halogenosilane Surface Modification. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42353108 | PubMed |
| 42251116 | Green mycosynthesis of small-sized silver nanoparticles (ss-AgNPs) from endophytic Fusarium solani and their multi-target biomedical profiles. | Sci Rep | 2026 | https://conductscience.org/library/papers/42251116 | PubMed |
| 42232528 | Environmental applications of silver nanoparticles: state-of-the-art review and emerging trends. | Beilstein J Nanotechnol | 2026 | https://conductscience.org/library/papers/42232528 | PubMed |
| 42226818 | Equal nano-characteristics, unequal harm: the chemical composition of noble metal nanoparticles as the main factor of cytotoxicity. | Front Toxicol | 2026 | https://conductscience.org/library/papers/42226818 | PubMed |
| 42043104 | Human Health Risk Assessment During the Synthesis and Application of Engineered Nanomaterials in a Controlled Laboratory Environment. | Toxics | 2026 | https://conductscience.org/library/papers/42043104 | PubMed |
| 41977130 | Cyclic Olefin Copolymer with a Noble Metal Nanostructures as an Antibacterial Material. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41977130 | PubMed |
| 41976456 | Crosslinked-AuNPs@CD-MOF Incorporated into PLA-Zein Composite Film with Humidity-Responsive Antimicrobial Release for Agaricus bisporus Preservation. | Foods | 2026 | https://conductscience.org/library/papers/41976456 | PubMed |
| 41969534 | Harnessing biogenic nanoparticles for combating antibiotic resistance: green synthesis, mechanistic insights, and biotechnological applications. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/41969534 | PubMed |
| 41901730 | Multidrug Resistance and Adaptive Response to Silver and Gold Nanoparticles in Methicillin-Resistant Staphylococcus aureus from Human and Animal Sources. | Pathogens | 2026 | https://conductscience.org/library/papers/41901730 | PubMed |
| 41745192 | Biosynthesis and Characterization of Staphylococcus sp. YRA-Derived Silver Nanoparticles with Antibacterial, Antibiofilm and Low Phytotoxic Effects. | Nanomaterials (Basel) | 2026 | https://conductscience.org/library/papers/41745192 | PubMed |
| 41683689 | Biogenesis of Candida glabrata-Mediated Silver Nanoparticles: Characterization and Antibacterial Effectiveness Against Human Pathogenic Bacteria. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41683689 | PubMed |
| 41625378 | Harnessing nanozymes as next-generation antimicrobial agents: From mechanisms to therapeutic strategies. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/41625378 | PubMed |
| 41415194 | Biosynthesis of silver and gold nanoparticles using cyanobacteria, their pharmaceutical and industrial applications. | RSC Adv | 2025 | https://conductscience.org/library/papers/41415194 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39338299
GET https://conductscience.org/api/papers/v1/39338299/references?page=2